Related Experiment Video

Updated: Jun 12, 2026

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
04:30

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Published on: February 4, 2021

[Natural course of aortic valve stenosis in patients with normal and abnormal lipid profile]

Jolanta Swierszcz1, Jacek S Dubiel, Tomasz Milewicz

  • 1II Klinika Kardiologii Collegium Medicum, Uniwersytetu Jagiellońskiego. grasshoppers@interia.eu

Przeglad Lekarski
|June 19, 2010
PubMed

Insights

Hypercholesterolemia may accelerate aortic valve stenosis (AVS) progression. Echocardiographic findings showed worsening AVS in patients with high cholesterol, suggesting shared risk factors with atherosclerosis.

Area of Science:

  • Cardiology
  • Biochemistry
  • Medical Imaging

Background:

  • Aortic valve stenosis (AVS) is a significant cardiovascular condition.
  • The role of hypercholesterolemia in AVS progression requires further elucidation.

Purpose of the Study:

  • To compare echocardiographic findings in AVS patients with and without hypercholesterolemia.
  • To observe the natural course of AVS over 12 months in relation to cholesterol levels.

Main Methods:

  • Sixty AVS patients unwilling to undergo surgery were divided into two groups based on serum total cholesterol levels.
  • Biochemical markers (total cholesterol, HDL, LDL, triglycerides, Lp(a)) and echocardiographic parameters were assessed over 12 months.

Main Results:

  • Patients with high cholesterol (Group A) showed increased aortic valve gradients (AOG max, AOG mean, V max) and left ventricular posterior wall thickness.
  • Left atrial diameter increased and aortic valve area decreased significantly in Group A.
  • While total cholesterol remained stable in Group A, it increased in Group B. HDL decreased in Group A, and LDL increased in Group B.

Conclusions:

  • Hypercholesterolemia is associated with accelerated progression of aortic valve stenosis.
  • The findings suggest potential shared risk factors between AVS progression and atherosclerosis.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...